Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 136 AL 150

Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials

O'Regan J, Lanctôt KL, Mazereeuw G, Herrmann N.

J Clin Psychiatry. 2015 Nov;76(11):e1424-31. doi: 10.4088/JCP.14r09237.

Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics

Cheng X, Zhang L, Lian YJ.

Biomed Res Int. 2015;2015:760758. doi: 10.1155/2015/760758. Epub 2015 Nov 19.

ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease

Shibuya Y, Chang CC, Chang TY.

Future Med Chem. 2015;7(18):2451-67. doi: 10.4155/fmc.15.161. Epub 2015 Dec 15.

[Coordinated care is paying off]

Rex C, Meier AG, Bischofberger I.

Krankenpfl Soins Infirm. 2015;108(7):14-6.

New Drugs from Marine Organisms in Alzheimer's Disease

Russo P, Kisialiou A, Lamonaca P, Moroni R, Prinzi G, Fini M.

Mar Drugs. 2015 Dec 25;14(1):5. doi: 10.3390/md14010005.

Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis

Ye R, Hu Y, Yao A, Yang Y, Shi Y, Jiang Y, Zhang J.

Int J Clin Pract. 2015 Jun;69(6):674-81. doi: 10.1111/ijcp.12626. Epub 2015 Feb 27.

CLINICAL PRACTICE. Advanced Dementia

Mitchell SL.

N Engl J Med. 2015 Jun 25;372(26):2533-40. doi: 10.1056/NEJMcp1412652.

Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer's disease and related dementias

Hennekens CH, Bensadon BA, Zivin R, Gaziano JM.

Expert Rev Neurother. 2015;15(11):1245-8. doi: 10.1586/14737175.2015.1088784. Epub 2015 Oct 8.

Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?

Cary MS, Rubright JD, Grill JD, Karlawish J.

Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):70-4. doi: 10.1097/WAD.0000000000000047.

Impact of a therapeutic educational program on quality of life in Alzheimer's disease: results of a pilot study

Villars H, Dupuy C, Perrin A, Vellas B, Nourhashemi F.

J Alzheimers Dis. 2015;43(1):167-76. doi: 10.3233/JAD-141179.

Physiotherapy intervention in Alzheimer's disease: systematic review and meta-analysis

Zhu XC, Yu Y, Wang HF, Jiang T, Cao L, Wang C, Wang J, Tan CC, Meng XF, Tan L, Yu JT.

J Alzheimers Dis. 2015;44(1):163-74. doi: 10.3233/JAD-141377.

Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study

Olde Rikkert MG, Verhey FR, Blesa R, von Arnim CA, Bongers A, Harrison J, Sijben J, Scarpini E, Vandewoude MF, Vellas B, Witkamp R, Kamphuis PJ, Scheltens P.

J Alzheimers Dis. 2015;44(2):471-80. doi: 10.3233/JAD-141305.

Trazodone and cognitive performance in Alzheimer disease

Camargos EF, Quintas JL, Louzada LL, Naves JO, Furioso AC, Nóbrega OT.

J Clin Psychopharmacol. 2015 Feb;35(1):88-9. doi: 10.1097/JCP.0000000000000237.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias